Overview
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| CerRx looks to advance IV formulation of much-studied fenretinide for cancer | A midstage drug development company is hoping that a meeting with the U.S. Food and Drug Administration this summer will help it set a course for pushing a promising new targeted cancer therapeutic through commercialization, starting with a... |
Reviews 0
FAQ about CerRx
What has the press written about CerRx?
Parsers VC has collected 2 articles mentioning CerRx, among them “CerRx looks to advance IV formulation of much-studied fenretinide for cancer”.
Is CerRx still active?
Yes, CerRx is active; its latest activity on Parsers VC dates from Jun 21, 2012.